Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

251 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers.
Hirshfield KM, Tolkunov D, Zhong H, Ali SM, Stein MN, Murphy S, Vig H, Vazquez A, Glod J, Moss RA, Belyi V, Chan CS, Chen S, Goodell L, Foran D, Yelensky R, Palma NA, Sun JX, Miller VA, Stephens PJ, Ross JS, Kaufman H, Poplin E, Mehnert J, Tan AR, Bertino JR, Aisner J, DiPaola RS, Rodriguez-Rodriguez L, Ganesan S. Hirshfield KM, et al. Among authors: dipaola rs. Oncologist. 2016 Nov;21(11):1315-1325. doi: 10.1634/theoncologist.2016-0049. Epub 2016 Aug 26. Oncologist. 2016. PMID: 27566247 Free PMC article.
Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers.
Rodriguez-Rodriguez L, Hirshfield KM, Rojas V, DiPaola RS, Gibbon D, Hellmann M, Isani S, Leiser A, Riedlinger GM, Wagreich A, Ali SM, Elvin JA, Miller VA, Ganesan S. Rodriguez-Rodriguez L, et al. Among authors: dipaola rs. Gynecol Oncol. 2016 Apr;141(1):2-9. doi: 10.1016/j.ygyno.2016.02.021. Gynecol Oncol. 2016. PMID: 27016222 Free PMC article. Clinical Trial.
Precision Medicine: Implications for Science and Practice.
Ganesan S, Rodriguez-Rodriguez L, DiPaola RS. Ganesan S, et al. Among authors: dipaola rs. J Am Coll Surg. 2016 Sep;223(3):433-439.e1. doi: 10.1016/j.jamcollsurg.2016.05.020. Epub 2016 Jun 16. J Am Coll Surg. 2016. PMID: 27321387 No abstract available.
Phase 2 trial of paclitaxel, 13-cis retinoic acid, and interferon alfa-2b in the treatment of advanced stage or recurrent cervical cancer.
Song M, DiPaola RS, Cracchiolo BM, Gibbon DG, Hellmann M, Nieves-Neira W, Vaidya A, Wagreich AR, Shih WJ, Rodriguez-Rodriguez L. Song M, et al. Among authors: dipaola rs. Int J Gynecol Cancer. 2014 Nov;24(9):1636-41. doi: 10.1097/IGC.0000000000000258. Int J Gynecol Cancer. 2014. PMID: 25304678 Free PMC article. Clinical Trial.
Bcl-2 modulation to activate apoptosis in prostate cancer.
Bray K, Chen HY, Karp CM, May M, Ganesan S, Karantza-Wadsworth V, DiPaola RS, White E. Bray K, et al. Among authors: dipaola rs. Mol Cancer Res. 2009 Sep;7(9):1487-96. doi: 10.1158/1541-7786.MCR-09-0166. Epub 2009 Sep 8. Mol Cancer Res. 2009. PMID: 19737977 Free PMC article.
Transdermal estradiol in castrate and chemotherapy resistant prostate cancer.
Stein M, Goodin S, Doyle-Lindrud S, Silberberg J, Kane M, Metzger D, Eddy S, Shih W, DiPaola RS. Stein M, et al. Among authors: dipaola rs. Med Sci Monit. 2012 Apr;18(4):CR260-4. doi: 10.12659/msm.882626. Med Sci Monit. 2012. PMID: 22460098 Free PMC article. Clinical Trial.
251 results